Searched by
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M203-1 |
HLA-A*02:01 HPV16 E7 Tetramer-LLMGTLGIV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLMGTLGIV | 82-90 | 4°C | ||||
|
TC-8033-1 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | ||||
|
TC-8021-1 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | 4°C | ||||
|
TS-M622-2 |
H-2Kb STAT3 Tetramer-ATLVFHNL-APC |
|
|||
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| ATLVFHNL | 53-60 | 4°C | ||||
|
TS-M607-1 |
H-2Kb MCMV M38 Tetramer-SSPPMFRV-PE |
|
|||
|
virus | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| SSPPMFRV | 316-323 | 4°C | ||||
|
TS-M605-1 |
H-2Dd MCMC M18 Tetramer-SGPSRGRII-PE |
|
|||
|
virus | PE | H-2Dd | 50 tests |
0 (Contact us) |
|
| SGPSRGRII | 348-356 | 4°C | ||||
|
TS-M604-1 |
H-2Db KDM5D Tetramer-KCSRNRQYL-PE |
|
|||
|
Others | PE | H-2Db | 50 tests |
0 (Contact us) |
|
| KCSRNRQYL | 738-746 | 4°C | ||||
|
TS-M201-1 |
HLA-A*01:01 TRIP12 Neoepitope Tetramer-PSDTRQMLFY-PE |
|
|||
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| PSDTRQMLFY | 4°C | |||||
|
TC-8030-1 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | ||||
|
TS-M612-2 |
H-2Kb RPL18 Tetramer-KILTFDQL-APC |
|
|||
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| KILTFDQL | 119-126 | 4°C | ||||
|
TS-M206-2 |
HLA-A*02:01 HCV polyprotein Tetramer-LLFNILGGWV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFNILGGWV | 1807-1816 | 4°C | ||||
|
TS-M248-1 |
HLA-A*02:01 Insulin Tetramer-ALWGPDPAAA-PE |
|
|||
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALWGPDPAAA | 15-24 | 4°C | ||||
|
TC-8029-1 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | 4°C | ||||
|
TC-8017-1 |
HLA-A*02:01 AFP158-166 Tetramer-FMNKFIYEI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMNKFIYEI | 158-166 | 4°C | ||||
|
TS-M609-2 |
H-2Kb MuHV-4 R1 Tetramer-TSINFVKI-APC |
|
|||
|
virus | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| TSINFVKI | 524-531 | 4°C | ||||
|
TS-M606-2 |
H-2Kb Influenza M1 Tetramer-MGLIYNRM-APC |
|
|||
|
virus | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| MGLIYNRM | 128-135 | 4°C | ||||
|
TS-M602-1 |
H-2Db LCMV gp Tetramer-CSANNSHHYI-PE |
|
|||
|
virus | PE | H-2Db | 50 tests |
0 (Contact us) |
|
| CSANNSHHYI | 92-101 | 4°C | ||||
|
TS-M246-1 |
HLA-A*02:01 GOLGA3 Neoepitope Tetramer-SLDLTTSPV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLDLTTSPV | 4°C | |||||
|
TS-M242-1 |
HLA-A*02:01 MCT2 Neoepitope Tetramer-AMAGSLVFL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| AMAGSLVFL | 4°C | |||||
|
TC-8034-2 |
HLA-A*03:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | 4°C | ||||
|
TC-8033-2 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | ||||
|
TC-8032-2 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | ||||
|
TC-8013-1 |
HLA-A*02:01 KRAS5-14 G12C Tetramer-KLVVVGACGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGACGV | 5-14 | 4°C | ||||
|
TS-M615-2 |
H-2Kb DDX6 Tetramer-INFDFPKL-APC |
|
|||
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| INFDFPKL | 407-414 | 4°C | ||||
|
TS-M268-2 |
HLA-A*24:02 p53 Tetramer-TYSPALNKMF-APC |
|
|||
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| TYSPALNKMF | 125-134 | 4°C | ||||
|
TS-M264-2 |
HLA-A*11:01 EBV BRLF1 Tetramer-ATIGTAMYK-APC |
|
|||
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATIGTAMYK | 134-142 | 4°C | ||||
|
TS-M263-2 |
HLA-A*11:01 Perilipin-2 Tetramer-TSALPIIQK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| TSALPIIQK | 63-71 | 4°C | ||||
|
TS-M273-1 |
HLA-B*07:02 TTBK2 Neoepitope Tetramer-RPHHDQRSL-PE |
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHHDQRSL | 4°C | |||||
|
TS-M263-1 |
HLA-A*11:01 Perilipin-2 Tetramer-TSALPIIQK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| TSALPIIQK | 63-71 | 4°C | ||||
|
TS-M262-1 |
HLA-A*11:01 KIF26B Neoepitope Tetramer-SSYTGFANK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSYTGFANK | 4°C | |||||
|
TC-8030-2 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | ||||
|
TC-8017-2 |
HLA-A*02:01 AFP158-166 Tetramer-FMNKFIYEI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMNKFIYEI | 158-166 | 4°C | ||||
|
TC-8007-2 |
HLA-A*02:01 P53168-176 Tetramer-HMTEVVRRC-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRRC | 168-176 | 4°C | ||||
|
TS-M257-2 |
HLA-A*11:01 HBcAg Tetramer-STLPETTVVRR-APC |
|
|||
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| STLPETTVVRR | 141-151 | 4°C | ||||
|
TS-M250-2 |
HLA-A*02:01 EBV BRLF1 Tetramer-YVLDHLIVV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YVLDHLIVV | 109-117 | 4°C | ||||
|
TS-M260-1 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| CILGKLFTK | 4°C | |||||
|
TC-8018-1 |
HLA-A*02:01 HBV194-202 Tetramer-FLLTKILTI-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTKILTI | 194-202 | 4°C | ||||
|
TS-M604-2 |
H-2Db KDM5D Tetramer-KCSRNRQYL-APC |
|
|||
|
Others | APC | H-2Db | 50 tests |
0 (Contact us) |
|
| KCSRNRQYL | 738-746 | 4°C | ||||
|
TS-M256-2 |
HLA-A*11:01 Dengue virus NS3 Tetramer-GTSGSPIIDK-APC |
|
|||
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| GTSGSPIIDK | 133-142 | 4°C | ||||
|
TS-M615-1 |
H-2Kb DDX6 Tetramer-INFDFPKL-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| INFDFPKL | 407-414 | 4°C | ||||
|
TS-M608-1 |
H-2Kb MCMV M139 Tetramer-TVYGFCLL-PE |
|
|||
|
virus | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| TVYGFCLL | 419-426 | 4°C | ||||
|
TS-M270-1 |
HLA-B*07:02 KIF16B Neoepitope Tetramer-APARLERRHSA-PE |
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| APARLERRHSA | 4°C | |||||
|
TS-M261-1 |
HLA-A*11:01 MATN2 Neoepitope Tetramer-KTLTSVFQK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| KTLTSVFQK | 4°C | |||||
|
TS-M213-1 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ACDPHSGHFV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ACDPHSGHFV | 4°C | |||||
|
TC-8008-1 |
HLA-A*02:01 HPV29-38 Tetramer-TIHDIILECV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| TIHDIILECV | 29-38 | 4°C | ||||
|
TS-M610-2 |
H-2Kb SGK1 Tetramer-STLTYSRM-APC |
|
|||
|
cancer | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| STLTYSRM | 10-17 | 4°C | ||||
|
TS-M276-2 |
HLA-B*07:02 DOPEY2 Neoepitope Tetramer-KPFCVLISL-APC |
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPFCVLISL | 4°C | |||||
|
TS-M203-2 |
HLA-A*02:01 HPV16 E7 Tetramer-LLMGTLGIV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLMGTLGIV | 82-90 | 4°C | ||||
|
TS-M257-1 |
HLA-A*11:01 HBcAg Tetramer-STLPETTVVRR-PE |
|
|||
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| STLPETTVVRR | 141-151 | 4°C | ||||
|
TS-M253-1 |
HLA-A*03:01 GPNMB Neoepitope Tetramer-TLDWLLQTPK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| TLDWLLQTPK | 4°C | |||||
|
TS-M244-1 |
HLA-A*02:01 FNDC3B Neoepitope Tetramer-VVMSWAPPV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVMSWAPPV | 4°C | |||||
|
TS-M216-1 |
HLA-A*02:01 HAUS3 Neoepitope Tetramer-ILNAMIAKI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILNAMIAKI | 4°C | |||||
|
TS-M207-1 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDPHSGHFV | 4°C | |||||
|
TS-M272-2 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-APC |
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPSDTPRPVM | 4°C | |||||
|
TS-M261-2 |
HLA-A*11:01 MATN2 Neoepitope Tetramer-KTLTSVFQK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| KTLTSVFQK | 4°C | |||||
|
TS-M211-2 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALIHHNTYL | 4°C | |||||
|
TS-M266-1 |
HLA-A*24:02 COASY Neoepitope Tetramer-RFLEYLPLRF-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| RFLEYLPLRF | 4°C | |||||
|
TS-M232-1 |
HLA-A*02:01 MRM1 Neoepitope Tetramer-LLFGMPPCL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFGMPPCL | 4°C | |||||
|
TC-8013-2 |
HLA-A*02:01 KRAS5-14 G12C Tetramer-KLVVVGACGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGACGV | 5-14 | 4°C | ||||
|
TS-M231-2 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| NLNCCSVPV | 4°C | |||||
|
TS-M217-2 |
HLA-A*02:01 ME3 Neoepitope Tetramer-FLDEFMEGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDEFMEGV | 4°C | |||||
|
TS-M620-1 |
H-2Kb YPEL3 Tetramer-RAYLFNSV-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| RAYLFNSV | 47-54 | 4°C | ||||
|
TS-M247-1 |
HLA-A*02:01 AGMO Neoepitope Tetramer-ALLQVTLLL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLQVTLLL | 4°C | |||||
|
TS-M235-1 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HIAKSLFEV | 4°C | |||||
|
TS-M223-1 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-VLENFTIFLV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLENFTIFLV | 4°C | |||||
|
TS-M204-1 |
HLA-A*02:01 HCV polyprotein Tetramer-YLLPRRGPRL-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLPRRGPRL | 35-44 | 4°C | ||||
|
TC-8020-1 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | 4°C | ||||
|
TC-8011-1 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | 4°C | ||||
|
TC-8009-2 |
HLA-A*02:01 MAGE-A4286-294 Tetramer-KVLEHVVRV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEHVVRV | 286-294 | 4°C | ||||
|
TS-M617-2 |
H-2Kb RPS15A Tetramer-VIVRFLTV-APC |
|
|||
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| VIVRFLTV | 33-40 | 4°C | ||||
|
TS-M269-2 |
HLA-B*07:02 UBR4 Neoepitope Tetramer-RPHVPESAF-APC |
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHVPESAF | 4°C | |||||
|
TS-M248-2 |
HLA-A*02:01 Insulin Tetramer-ALWGPDPAAA-APC |
|
|||
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALWGPDPAAA | 15-24 | 4°C | ||||
|
TS-M238-2 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAALFLGL | 4°C | |||||
|
TS-M225-2 |
HLA-A*02:01 Hsp70 Neoepitope Tetramer-SLFEGIDIYT-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFEGIDIYT | 4°C | |||||
|
TS-M213-2 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ACDPHSGHFV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ACDPHSGHFV | 4°C | |||||
|
TS-M208-2 |
HLA-A*02:01 p53 Neoepitope Tetramer-VVPCEPPEV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVPCEPPEV | 4°C | |||||
|
TS-M611-1 |
H-2Kb β-catenin Tetramer-RTYTYEKL-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| RTYTYEKL | 329-336 | 4°C | ||||
|
TS-M268-1 |
HLA-A*24:02 p53 Tetramer-TYSPALNKMF-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| TYSPALNKMF | 125-134 | 4°C | ||||
|
TS-M237-1 |
HLA-A*02:01 GCN1 Neoepitope Tetramer-ALLETPSLLL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLETPSLLL | 4°C | |||||
|
TS-M226-1 |
HLA-A*02:01 Astrotactin-1 Neoepitope Tetramer-KLYGLDWAEL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLYGLDWAEL | 4°C | |||||
|
TS-M221-1 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYGFVPVL | 4°C | |||||
|
TS-M210-1 |
HLA-A*02:01 AHNAK Neoepitope Tetramer-FMPDFDLHL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMPDFDLHL | 4°C | |||||
|
TS-M208-1 |
HLA-A*02:01 p53 Neoepitope Tetramer-VVPCEPPEV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVPCEPPEV | 4°C | |||||
|
TC-8019-2 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | 4°C | ||||
|
TC-8019-1 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | 4°C | ||||
|
TC-8018-2 |
HLA-A*02:01 HBV194-202 Tetramer-FLLTKILTI-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTKILTI | 194-202 | 4°C | ||||
|
TC-8008-2 |
HLA-A*02:01 HPV29-38 Tetramer-TIHDIILECV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| TIHDIILECV | 29-38 | 4°C | ||||
|
TS-M270-2 |
HLA-B*07:02 KIF16B Neoepitope Tetramer-APARLERRHSA-APC |
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| APARLERRHSA | 4°C | |||||
|
TS-M230-2 |
HLA-A*02:01 USP28 Neoepitope Tetramer-LIIPFIHLI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LIIPFIHLI | 4°C | |||||
|
TS-M222-2 |
HLA-A*02:01 NSDHL Neoepitope Tetramer-ILTGLNYEV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILTGLNYEV | 4°C | |||||
|
TS-M221-2 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYGFVPVL | 4°C | |||||
|
TS-M218-2 |
HLA-A*02:01 ACTN1 Neoepitpe Tetramer-FIASNGVKLV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FIASNGVKLV | 4°C | |||||
|
TS-M215-2 |
HLA-A*02:01 WDR46 Neoepitope Tetramer-FLIYLDVSV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLIYLDVSV | 4°C | |||||
|
TS-M210-2 |
HLA-A*02:01 AHNAK Neoepitope Tetramer-FMPDFDLHL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMPDFDLHL | 4°C | |||||
|
TS-M277-1 |
HLA-B*08:01 FAM50B Neoepitope Tetramer-DMKARQKALV-PE |
|
|||
|
cancer | PE | B*08:01 | 50 tests |
0 (Contact us) |
|
| DMKARQKALV | 4°C | |||||
|
TS-M265-1 |
HLA-A*24:02 β-catenin Neoepitope Tetramer-SYLDSGIHF-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| SYLDSGIHF | 4°C | |||||
|
TS-M231-1 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| NLNCCSVPV | 4°C | |||||
|
TS-M214-1 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLLGVKLFGV | 4°C | |||||
|
TS-M211-1 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALIHHNTYL | 4°C | |||||
|
TS-M205-1 |
HLA-A*02:01 HCV polyprotein Tetramer-DLMGYIPLV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| DLMGYIPLV | 132-140 | 4°C | ||||